US Code - Part A: Drugs and devices

Section 351 Adulterated drugs and devices
Section 352 Misbranded drugs and devices
Section 353 Exemptions and consideration for certain drugs, devices, and biological products
Section 353A Pharmacy compounding
Section 354 Veterinary feed directive drugs
Section 355 New drugs
Section 355A Pediatric studies of drugs
Section 355B Adverse-event reporting
Section 355C Research into pediatric uses for drugs and biological products
Section 356 Fast track products
Section 356-1 Accelerated approval of priority countermeasures
Section 356A Manufacturing changes
Section 356B Reports of postmarketing studies
Section 356C Discontinuance of life saving product
Section 357 Repealed. Pub. L. 105-115, title I, Sec. 125(b)(1), Nov. 21, 1997, 111 Stat. 2325
Section 358 Authority to designate official names
Section 359 Nonapplicability of subchapter to cosmetics
Section 360 Registration of producers of drugs or devices
Section 360A Repealed. Pub. L. 91-513, title II, Sec. 701(a), Oct. 27, 1970, 84 Stat. 1281
Section 360B New animal drugs
Section 360C Classification of devices intended for human use
Section 360D Performance standards
Section 360E Premarket approval
Section 360F Banned devices
Section 360G Judicial review
Section 360H Notification and other remedies
Section 360I Records and reports on devices
Section 360J General provisions respecting control of devices intended for human use
Section 360K State and local requirements respecting devices
Section 360L Postmarket surveillance
Section 360M Accredited persons

Drugs and devices

Drugs for rare diseases or conditions